Related Experiment Videos
Therapy for deep mycoses: an introduction.
1University of Brussels, Belgium.
Proceedings of the Royal Society of Medicine
|January 1, 1977
Summary
This study classifies fungal infections (mycoses) by depth and differentiates true from pseudo-mycoses. Effective antifungal treatment relies on accurate patient pathological assessment and safe, effective drug selection.
Area of Science:
- Medical Mycology
- Pharmacology
Background:
- Mycoses classification requires differentiation between true and pseudo-infections based on pathogen penetration depth.
- The evolution of antifungal agents has progressed from early antibiotics to modern drugs like amphotericin B and 5-fluorocytosine.
Purpose of the Study:
- To discuss a classification system for mycoses based on organism penetration depth.
- To review the historical development and current status of antifungal agents.
- To emphasize the importance of patient-specific pathological assessment for successful antifungal therapy.
Main Methods:
- Literature review on mycoses classification and antifungal drug development.
- Analysis of safety and effectiveness data for antifungal agents.
- Case examples illustrating the link between clinical assessment and treatment outcomes.
Main Results:
- A classification framework for mycoses is presented.
- Key antifungal agents, including amphotericin B and 5-fluorocytosine, are discussed regarding their safety and efficacy.
- The critical role of precise pathological diagnosis in guiding antifungal treatment is highlighted.
Conclusions:
- Accurate classification of mycoses and understanding of antifungal agent properties are essential.
- Successful treatment outcomes are contingent upon thorough patient evaluation and tailored therapeutic strategies.